p53 and p53-regulated genes in bladder cancer.
Keegan
P E
PE
Department of Surgery, The Medical School, University of Newcastle, Newcastle upon Tyne, UK.
Lunec
J
J
Neal
D E
DE
D017209:Apoptosis / Q000235:genetics; D019938:Cyclin D1 / Q000037:antagonists & inhibitors; D015972:Gene Expression Regulation, Neoplastic; D019254:Genes, bcl-2 / Q000235:genetics; D016158:Genes, p53 / Q000235:genetics*; D006801:Humans; D009687:Nuclear Proteins; D011518:Proto-Oncogene Proteins / Q000235:genetics; D051736:Proto-Oncogene Proteins c-mdm2; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics; D012175:Retinoblastoma / Q000235:genetics; D019699:Thrombospondins / Q000235:genetics; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*; D001749:Urinary Bladder Neoplasms / Q000235:genetics*
D009687:Nuclear Proteins; D011518:Proto-Oncogene Proteins; D019699:Thrombospondins; D016159:Tumor Suppressor Protein p53; D019938:Cyclin D1; C497206:MDM2 protein, human; D051736:Proto-Oncogene Proteins c-mdm2; C501009:HRAS protein, human; D016283:Proto-Oncogene Proteins p21(ras)